Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Neogen Corporation(NEOG)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for NEOG
10/19/2026: NEOG (5-star) is currently NOT-A-BUY. Pass it for now.
Neogen Corporation is a global provider of diagnostic and genomic solutions for the food and animal safety industries. The company is known for its strong position in food-plant testing and its integrated approach to livestock productivity. Its primary growth story revolves around the recent, transformational acquisition of 3M's Food Safety business, which has substantially expanded its scale and reach. However, investors must monitor the execution risks associated with this large integration and the competitive landscape involving major life science firms. Suited primarily for growth-oriented investors, the stock remains a key participant in the essential global food supply chain, with performance tied to operational efficiency.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Neogen targets long-term expansion in the essential, recurring-revenue food safety and animal health markets. |
| Momentum investor | Mixed fit | This style is conditional on positive technical price trends and successful execution of current merger synergies. |
| Value investor | Mixed fit | Valuation is often premium due to the company's growth profile, requiring disciplined entry points. |
| Dividend investor | Weak fit | Neogen does not currently pay a dividend, focusing all available capital on growth and debt reduction. |
| Low-risk investor | Weak fit | The company’s focus on R&D and integration carries inherent operational risks that may lead to stock price volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock can experience sharp moves based on quarterly integration progress and broader agricultural market data. |
| Valuation risk | Medium | Market expectations for growth and synergy realization are high, leaving little room for operational misses. |
| Competition risk (Diagnostics & Genomics) | Medium / high | The company competes against large, well-capitalized firms like Thermo Fisher and Zoetis. |
| Business quality | Strong | The company holds strong, sticky market positions in essential food testing and animal diagnostic supply chains. |
| Dividend income | Low / none | Investors should not rely on the stock for regular income as cash is prioritized for growth. |
| Execution risk | Medium / high | Successfully integrating the massive 3M Food Safety business is critical to long-term profitability. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 71.18% | Avg. Invested days 41 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  4.0 |
| Profits based on simulation | Last Close 10/19/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.58B USD | Price to earnings Ratio - | 1Y Target Price 14 |
Price to earnings Ratio - | 1Y Target Price 14 | ||
Volume (30-day avg) 4.7M shares | Beta 1.79 | 52 Weeks Range 5.37 - 14.26 | Updated Date 10/18/2026 |
52 Weeks Range 5.37 - 14.26 | Updated Date 10/18/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.26 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Food Safety | Diagnostic test kits, Petrifilm plates, and related laboratory equipment. | The company makes steady money selling recurring supplies that food processors need to comply with health safety regulations. |
| Animal Safety | Genomic testing, veterinary instruments, and animal healthcare products. | Revenue is generated from livestock producers and pet owners needing health and diagnostic solutions. |
| Geographic Exposure | Global sales across North America, Europe, and emerging markets. | Neogen's reach into global food supply chains provides a diversified revenue base across different regulatory environments. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-10-06 | When After Market | Estimate 0.04 | Actual 0.07 |
Profitability
Profit Margin -6.35% | Operating Margin (TTM) -0.81% |
Management Effectiveness
Return on Assets (TTM) -0.14% | Return on Equity (TTM) -2.67% |
Valuation
Trailing PE - | Forward PE 16 | Enterprise Value 3.57B | Price to Sales(TTM) 2.92 |
Enterprise Value 3.57B | Price to Sales(TTM) 2.92 | ||
Enterprise Value to Revenue 4.1 | Enterprise Value to EBITDA 20.92 | Shares Outstanding 218.31M | Shares Floating 217.33M |
Shares Outstanding 218.31M | Shares Floating 217.33M | ||
Percent Insiders 0.75 | Percent Institutions 110.8 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.